Soligenix

#药闻简讯# $Soligenix(SNGX)$ SGX945 二期临床试验在 Behçet 病治疗方面取得积极结果，发表于《牛津风湿病学》杂志

$Soligenix(SNGX)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001172661-25-005144  Act: 34  Size: 10 KB 网页链接

$Soligenix(SNGX)$ Armistice Capital, LLC及Steven Boyd已提交13G表格，报告持有Soligenix, Inc. 6.72%的股权。文件显示，作为Armistice Capital Master Fund Ltd.的投资管理人，Armistice Capital, LLC对Soligenix的708,000股普通股行使投票权和投资权。这些股份由Master Fund持有，但该基金声明...

$Soligenix(SNGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001787282-25-000004  Size: 5 KB 网页链接

$Soligenix(SNGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001595197-25-000003  Size: 5 KB 网页链接

$Soligenix(SNGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001068029-25-000005  Size: 5 KB 网页链接

$Soligenix(SNGX)$ 8-K Current report, items 3.01 and 9.01 Accession Number: 0001104659-25-113645  Act: 34  Size: 155 KB 网页链接

$Soligenix(SNGX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001627575-25-000003  Size: 5 KB 网页链接

$Soligenix(SNGX)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-26-006233  Act: 34  Size: 568 KB 网页链接

$Soligenix(SNGX)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-26-006255  Act: 33  Size: 480 KB 网页链接